Identification of Heregulin, a Specific Activator of p185 <sup>erbB2</sup>
1992 · Science · 963 citations
https://doi.org/10.1126/science.256.5060.1205
G
Gail D. Lewis Phillips
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
293
Papers
15.8K
Citations
48
h-index
83
i10-index
Gail D. Lewis Phillips is an academic researcher from Gene Therapy Laboratory. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Monoclonal and Polyclonal Antibodies Research & Breast Cancer Treatment Studies. The author has an h-index of 48, co-authored 250 publications.
ORCID: 0000-0001-7051-016XPapers by this author
worksLigand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
2009 · Cancer Cell · 825 citations
https://doi.org/10.1016/j.ccr.2009.03.020
Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers
1999 · Oncogene · 687 citations
https://doi.org/10.1038/sj.onc.1202526
p185 <i> <sup>HER2</sup> </i> Monoclonal Antibody Has Antiproliferative Effects In Vitro and Sensitizes Human Breast Tumor Cells to Tumor Necrosis Factor
1989 · Molecular and Cellular Biology · 663 citations
https://doi.org/10.1128/mcb.9.3.1165-1172.1989
Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies
1993 · Cancer Immunology Immunotherapy · 498 citations
https://doi.org/10.1007/bf01518520
Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
2010 · Clinical Cancer Research · 290 citations
https://doi.org/10.1158/1078-0432.ccr-10-0987
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat